JLM-BioCity Partner Concenter BioPharma

Concenter BioPharma
CEO & Founder: Dror Chevion 
Stage: Clinical trials
Year Established: 2019 

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., is developing a novel drug for treating and preventing type 2 diabetes. This drug act as:

  • Potent anti-inflammatory agents
  • Strong iron-chelating agents
  • Anti-biotic agents